SEARCH

SEARCH BY CITATION

References

  • 1
    Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 1989; 244: 359362.
  • 2
    Alter HJ. In: SeeffLB, LewisJH, eds. Current Perspectives in Hepatology. New York: Plenum, 1989: 8397.
  • 3
    Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993; 342: 435436.
  • 4
    Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 33393344.
  • 5
    Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 10061007.
  • 6
    Choo Q-L, Kuo G, Ralston R, Weiner AJ, Chien D, van Nest G, Han J, et al. Vaccination of chimpanzees against infection by hepatitis C virus. PNAS 1994; 91: 12941298.
  • 7
    Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135140.
  • 8
    Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343: 388390.
  • 9
    Courouce AM, Bouchardeau F, Chauveau P, Le MN, Girault A, Zins B, Naret C, et al. Hepatitis C virus (HCV) infection in haemodialysed patients. HCV RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995; 10: 234239.
  • 10
    Duvoux C, Pawlotsky JM, Cherqui D, Tran v NJ, Metreau JM, Fagniez PL, Duval J, et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 1995; 60: 457461.
  • 11
    Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68: 14941500.
  • 12
    Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. PNAS 1992; 89: 34683472.
  • 13
    Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994; 68: 47764784.
  • 14
    Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 1993; 195: 297301.
  • 15
    Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. PNAS 1996; 93: 17591763.
  • 16
    Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS 1994; 91: 77927796.
  • 17
    Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995; 208: 653661.
  • 18
    Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991; 13: 323327.
  • 19
    Kraas W, Ihlenfeldt H-G, Seidel C, Wienhues U, Schmitt U, Jung G. Proceedings of the 23rd European Peptide Symposium, ESCOM 1-827-828 Leiden, 1995.
  • 20
    Bonino F, Brunetto MR, Negro F, Baldi M, Saracco G, Abate ML, Fabiano A, et al. Hepatitis C virus infection and disease. Diagnostic problems. J Hepatol 1993; 17 (suppl 3): 7882.
  • 21
    Scarselli E, Cerino A, Esposito G, Silini E, Mondelli M, Traboni C. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 1995; 69: 44074412.
  • 22
    Höhne M, Schreier E, Roggendorf M. Sequence variability in the envcoding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol 1994; 137: 2534.
  • 23
    Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 10721075.
  • 24
    van Doom L-J, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, Schellekens H, et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral response. J Virol 1995; 69: 773778.